Medy-Tox Statistics

Total Valuation

Medy-Tox has a market cap or net worth of KRW 1.08 trillion. The enterprise value is 1.12 trillion.

Market Cap	1.08T
Enterprise Value	1.12T

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	Sep 27, 2024

Share Statistics

Medy-Tox has 6.58 million shares outstanding. The number of shares has increased by 0.40% in one year.

Current Share Class	n/a
Shares Outstanding	6.58M
Shares Change (YoY)	+0.40%
Shares Change (QoQ)	-23.31%
Owned by Insiders (%)	20.47%
Owned by Institutions (%)	10.54%
Float	4.79M

Valuation Ratios

The trailing PE ratio is 69.26 and the forward PE ratio is 25.96.

PE Ratio	69.26
Forward PE	25.96
PS Ratio	4.74
PB Ratio	2.27
P/TBV Ratio	2.40
P/FCF Ratio	38.91
P/OCF Ratio	29.62
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.15, with an EV/FCF ratio of 40.08.

EV / Earnings	69.80
EV / Sales	4.88
EV / EBITDA	24.15
EV / EBIT	42.53
EV / FCF	40.08

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.17.

Current Ratio	1.67
Quick Ratio	1.04
Debt / Equity	0.17
Debt / EBITDA	2.02
Debt / FCF	2.92
Interest Coverage	11.78

Financial Efficiency

Return on equity (ROE) is 3.38% and return on invested capital (ROIC) is 2.28%.

Return on Equity (ROE)	3.38%
Return on Assets (ROA)	2.07%
Return on Invested Capital (ROIC)	2.28%
Return on Capital Employed (ROCE)	4.04%
Revenue Per Employee	317.09M
Profits Per Employee	22.16M
Employee Count	721
Asset Turnover	0.37
Inventory Turnover	1.45

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +25.94% in the last 52 weeks. The beta is 0.12, so Medy-Tox's price volatility has been lower than the market average.

Beta (5Y)	0.12
52-Week Price Change	+25.94%
50-Day Moving Average	136,842.00
200-Day Moving Average	151,534.00
Relative Strength Index (RSI)	69.67
Average Volume (20 Days)	71,972

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medy-Tox had revenue of KRW 228.62 billion and earned 15.98 billion in profits. Earnings per share was 2,376.57.

Revenue	228.62B
Gross Profit	138.58B
Operating Income	20.35B
Pretax Income	17.50B
Net Income	15.98B
EBITDA	40.31B
EBIT	20.35B
Earnings Per Share (EPS)	2,376.57

Full Income Statement

Balance Sheet

The company has 59.51 billion in cash and 81.32 billion in debt, giving a net cash position of -21.80 billion or -3,314.11 per share.

Cash & Cash Equivalents	59.51B
Total Debt	81.32B
Net Cash	-21.80B
Net Cash Per Share	-3,314.11
Equity (Book Value)	476.65B
Book Value Per Share	69,966.38
Working Capital	74.88B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 36.56 billion and capital expenditures -8.73 billion, giving a free cash flow of 27.83 billion.

Operating Cash Flow	36.56B
Capital Expenditures	-8.73B
Free Cash Flow	27.83B
FCF Per Share	4,230.32

Full Cash Flow Statement

Margins

Gross margin is 60.62%, with operating and profit margins of 8.90% and 7.42%.

Gross Margin	60.62%
Operating Margin	8.90%
Pretax Margin	7.65%
Profit Margin	7.42%
EBITDA Margin	17.63%
EBIT Margin	8.90%
FCF Margin	12.17%

Dividends & Yields

This stock pays an annual dividend of 1,100.00, which amounts to a dividend yield of 0.68%.

Dividend Per Share	1,100.00
Dividend Yield	0.68%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	49.69%
Buyback Yield	-0.40%
Shareholder Yield	0.27%
Earnings Yield	1.48%
FCF Yield	2.57%

Dividend Details

Stock Splits

The last stock split was on December 28, 2022. It was a forward split with a ratio of 1.05.

Last Split Date	Dec 28, 2022
Split Type	Forward
Split Ratio	1.05

Scores

Medy-Tox has an Altman Z-Score of 6.31.

Altman Z-Score	6.31
Piotroski F-Score	n/a